These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 21763254

  • 1. Polymorphisms in CCR6 are associated with chronic graft-versus-host disease and invasive fungal disease in matched-related hematopoietic stem cell transplantation.
    Broen K, van der Waart AB, Greupink-Draaisma A, Metzig J, Feuth T, Schaap NP, Blijlevens NM, van der Velden WJ, Dolstra H.
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1443-9. PubMed ID: 21763254
    [Abstract] [Full Text] [Related]

  • 2. Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.
    Wermke M, Maiwald S, Schmelz R, Thiede C, Schetelig J, Ehninger G, Bornhäuser M, Wassmuth R.
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1718-27. PubMed ID: 20541026
    [Abstract] [Full Text] [Related]

  • 3. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation.
    Elmaagacli AH, Koldehoff M, Landt O, Beelen DW.
    Bone Marrow Transplant; 2008 May; 41(9):821-6. PubMed ID: 18209723
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Viel DO, Tsuneto LT, Sossai CR, Lieber SR, Marques SB, Vigorito AC, Aranha FJ, de Brito Eid KA, Oliveira GB, Miranda EC, de Souza CA, Visentainer JE.
    Scand J Immunol; 2007 Dec; 66(6):703-10. PubMed ID: 18021367
    [Abstract] [Full Text] [Related]

  • 11. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.
    Elmaagacli AH, Koldehoff M, Hindahl H, Steckel NK, Trenschel R, Peceny R, Ottinger H, Rath PM, Ross RS, Roggendorf M, Grosse-Wilde H, Beelen DW.
    Transplantation; 2006 Jan 27; 81(2):247-54. PubMed ID: 16436969
    [Abstract] [Full Text] [Related]

  • 12. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
    Wu J, Tang JL, Wu SJ, Lio HY, Yang YC.
    Clin Chim Acta; 2009 May 27; 403(1-2):229-33. PubMed ID: 19332044
    [Abstract] [Full Text] [Related]

  • 13. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation.
    Granell M, Urbano-Ispizua A, Suarez B, Rovira M, Fernández-Avilés F, Martínez C, Ortega M, Uriburu C, Gaya A, Roncero JM, Navarro A, Carreras E, Mensa J, Vives J, Rozman C, Montserrat E, Lozano F.
    Exp Hematol; 2006 Oct 27; 34(10):1435-41. PubMed ID: 16982337
    [Abstract] [Full Text] [Related]

  • 14. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.
    Karabon L, Wysoczanska B, Bogunia-Kubik K, Suchnicki K, Lange A.
    Hum Immunol; 2005 Jun 27; 66(6):700-10. PubMed ID: 15993715
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
    Shindo T, Ishikawa T, Fukunaga A, Hori T, Uchiyama T.
    Biol Blood Marrow Transplant; 2008 Mar 27; 14(3):268-81. PubMed ID: 18275893
    [Abstract] [Full Text] [Related]

  • 18. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation.
    Takahashi H, Furukawa T, Hashimoto S, Suzuki N, Kuroha T, Yamazaki F, Inano K, Takahashi M, Aizawa Y, Koike T.
    Bone Marrow Transplant; 2000 Dec 27; 26(12):1317-23. PubMed ID: 11223972
    [Abstract] [Full Text] [Related]

  • 19. Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.
    Elbahlawan L, McArthur J, Quasney MW, Pei D, Srivastava K, Dahmer MK, Barfield R.
    J Pediatr Hematol Oncol; 2012 Apr 27; 34(3):175-9. PubMed ID: 22395218
    [Abstract] [Full Text] [Related]

  • 20. ATM gene single nucleotide polymorphisms predict regimen-related gastrointestinal toxicity in patients allografted after reduced conditioning.
    Kuba A, Raida L, Mrazek F, Schneiderova P, Kriegova E, Furst T, Furstova J, Faber E, Ambruzova Z, Papajik T.
    Biol Blood Marrow Transplant; 2015 Jun 27; 21(6):1136-40. PubMed ID: 25759145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.